Virtual Presentation



Expanding the Efficacy of Targeted Agents: Future Directions in Solid Tumors (coming soon)


Faculty:

  • Angela Davies, MD

CME CREDIT INFORMATION

Release Date: 10/09/06

Expiration Date: 10/08/07


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the rationale for the expansion of novel therapeutic agents with proven efficacy in hematologic malignancies into the treatment of solid tumors
  • Evaluate the efficacy and safety of novel therapeutic agents with proven efficacy in the hematologic setting in the treatment of solid tumors

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Copyright © 2006 The Center for Biomedical Continuing Education.  All rights reserved.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Sponsored by The Center for Biomedical Continuing Education.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.